Skip to main content
STRIDES PHARMA SCIENCE LIMITED logo

STRIDES PHARMA SCIENCE LIMITED — Investor Relations & Filings

Ticker · STAR ISIN · INE939A01011 LEI · 335800WHFYXUCHR9DD10 BSE.NS Manufacturing
Open in API
Filings indexed 1,190 across all filing types
Latest filing 2024-06-27 Regulatory Filings
Country IN India
Listing BSE.NS STAR

About STRIDES PHARMA SCIENCE LIMITED

https://www.strides.com

Strides Pharma Science Limited is a global pharmaceutical organization focused on the development and manufacture of IP-led niche finished dosage formulations. The company’s product portfolio encompasses a wide range of therapeutic areas, specializing in complex oral solids, softgel capsules, topicals, and liquids. It maintains a significant presence in highly regulated markets, including the United States, Europe, and Australia, while also serving institutional and emerging markets. The company operates multiple manufacturing facilities globally, many of which are approved by major international regulatory agencies such as the USFDA. Strides emphasizes research and development to drive innovation in specialized delivery systems and difficult-to-manufacture products, positioning itself as a key player in the global generic pharmaceutical landscape.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings
2024-06-27 English
Shareholders meeting
Board/Management Information Classification · 95% confidence The document is a detailed notice of a Postal Ballot issued by Strides Pharma Science Limited, dated June 26, 2024. It includes information about the appointment of new directors and senior management, voting procedures, timelines for e-voting, and the resolutions to be approved by shareholders. The content focuses on governance matters, specifically appointments to the board and executive management, and the process for shareholder approval via postal ballot. It does not contain financial statements, audit opinions, earnings data, or other financial report content. It is not a report itself but a notice for shareholder voting on management appointments. Therefore, the document fits best under the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2024-06-26 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding compliance under SEBI regulations about the issuance of a duplicate share certificate to a shareholder. It includes details of the shareholder, old and new folio numbers, certificate numbers, and proof of dispatch. The content is a regulatory compliance update related to share certificates and does not contain financial data, management discussion, or report publication. It is not an annual report, earnings release, or any financial report. It is also not a voting result, board change, or capital update. The document is a regulatory announcement about share certificate issuance and compliance with listing obligations, fitting best under Regulatory Filings (RNS). The document length is short and it is a formal notification rather than a report or presentation.
2024-06-25 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is an intimation to stock exchanges regarding the issuance of a duplicate share certificate due to loss or misplacement by a shareholder. It references compliance with SEBI regulations and includes details about the shareholder and certificate numbers. There are no financial statements, earnings data, or management discussion. The document is a regulatory announcement about share certificate issuance and procedural compliance, not a financial report or meeting material. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2024-06-19 English
Retirement
Board/Management Information Classification · 95% confidence The document is a formal notification addressed to stock exchanges regarding the completion of tenure of an Independent Director, Mr. Bharat Dhirajlal Shah, at Strides Pharma Science Limited. It references compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of events or information by listed entities. The content focuses on a change in the board of directors, specifically the cessation of an Independent Director's term. There are no financial statements, earnings data, or detailed management discussion. The document is an announcement of a board/management change rather than a full report or financial filing. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is 2778 characters, which is relatively short and consistent with a regulatory announcement rather than a full report.
2024-06-14 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 99% confidence The document is a detailed transcript of an earnings conference call held on May 22, 2024, discussing the audited financial results for the quarter and year ended March 31, 2024. It includes management commentary on financial performance, business strategy, market outlook, and operational highlights. The presence of a moderator, management speakers, and Q&A format typical of earnings calls is evident. The document explicitly states it is an "Earnings Call transcript" and references the earnings call held on May 22, 2024. This matches the definition of a Call Transcript (CT), which is a full text transcript of company conference calls such as earnings calls with Q&A. The document is not a brief announcement or a report publication notice, but the full transcript itself, and contains substantive discussion of financial results and outlook. Therefore, the correct classification is CT with high confidence.
2024-05-27 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.